Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - SHORT-TERM INVESTMENTS
Short-term Investments ENTA - Enanta Pharmaceuticals, Inc.
211 M
LAST VALUE
1.38%
2 YEAR CAGR
-5.77%
5 YEAR CAGR
13.39%
10 YEAR CAGR